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Efecto del ketofol en la reducción de la tos causada por el fentanilo en pacientes sometidos a anestesia general
ABSTRACT
Fentanyl is now widely used for anesthetic and pain relief. Fentanyl with the 80-fold antinociceptive effect of morphine 
was introduced in the 1960s as an intravenous anesthetic in medicine. The incidence of fentanyl-related cough is reported 
to be about 80-28% and is an undesirable side effect of anesthesia. Its main application is as an analgesic and sedative pre-
anesthetic in the operating room. The aim of this study was to evaluate the effect of ketofol on couched induced fentanyl in 
patients undergoing general anesthesia. The is a randomized, double-blind clinical trial that has been done on 124 patients 
candidate for general anesthesia in age range 16-60 years which hospitalized in Fatemi and Imam hospitals in Ardabil city in 
year 2018. Checklist included demographic and clinical data collected for all patients. The first group received ketamine 2 
cc, the second group received propofol 2 cc (10 mg), the third group received ketofol 2 cc(propofol 10 mg + ketamine 10 mg 
1: 1), and the fourth group received normal saline 2 cc by orally. Then fentanyl (2 μg / kg) was administered to each of the 
4 groups. Coughing, severity and time of onset of it were recorded in time intervals per second in each of the four groups. 
Finally, all the data entered the statistical analysis program and analyzed by statistical methods in SPSS version 20. In this 
study, couch rate was 22.6%, 32.3%, 6.5% and 61.3% in ketamine, Propofol, ketofol and control group respectively. The 
highest cough delay was observed in the recipients of ketofol and propofol, and the highest premature cough was observed 
in the control group. Also, none of the prescribed drugs did significantly change the blood pressure, heart rate, and MAP in 
the control group. It was observed that ketofol, ketamine and propofol significantly reduced the cough rate compared with 
the control group. The results of this study showed that ketofol had the most fentanyl-induced cough suppressant compared 
to placebo and propofol, and it can be used a good medication for patients.
Keywords: Ketofol, Ketamine, Propofol, Fentanyl-induced cough, General anesthesia, Ardabil.
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RESUMEN
El fentanilo ahora se usa ampliamente para la anestesia y el alivio del dolor. El fentanilo con el efecto antinociceptivo 
80 veces mayor de la morfina se introdujo en la década de 1960 como un anestésico intravenoso en medicina. 
Se informa que la incidencia de tos relacionada con el fentanilo es de aproximadamente 80-28% y es un efecto 
secundario indeseable de la anestesia. Su aplicación principal es como preanestésico analgésico y sedante en 
quirófano. El objetivo de este estudio fue evaluar el efecto del ketofol sobre el fentanilo inducido en pacientes 
sometidos a anestesia general. El es un ensayo clínico aleatorizado, doble ciego que se realizó en 124 pacientes 
candidatos a anestesia general en un rango de edad de 16 a 60 años que se hospitalizó en los hospitales Fatemi 
e Imam en la ciudad de Ardabil en el año 2018. La lista de verificación incluyó datos demográficos y clínicos 
recopilados para todos los pacientes El primer grupo recibió ketamina 2 cc, el segundo grupo recibió propofol 2 cc 
(10 mg), el tercer grupo recibió ketofol 2 cc (propofol 10 mg + ketamina 10 mg 1: 1), y el cuarto grupo recibió 2 
cc de solución salina normal por oralmente. Luego se administró fentanilo (2 μg / kg) a cada uno de los 4 grupos. 
La tos, la gravedad y el tiempo de aparición se registraron en intervalos de tiempo por segundo en cada uno de 
los cuatro grupos. Finalmente, todos los datos ingresaron al programa de análisis estadístico y se analizaron por 
métodos estadísticos en SPSS versión 20. En este estudio, la tasa de cobertura fue de 22.6%, 32.3%, 6.5% y 61.3% 
en ketamina, Propofol, ketofol y grupo de control respectivamente. El mayor retraso de la tos se observó en los 
receptores de ketofol y propofol, y la mayor tos prematura se observó en el grupo de control. Además, ninguno 
de los medicamentos recetados cambió significativamente la presión arterial, la frecuencia cardíaca y la PAM en el 
grupo de control. Se observó que el ketofol, la ketamina y el propofol redujeron significativamente la tasa de tos 
en comparación con el grupo control. Los resultados de este estudio mostraron que el ketofol tenía el supresor de 
la tos más inducido por el fentanilo en comparación con el placebo y el propofol, y puede usarse como un buen 
medicamento para los pacientes.
Palabras clave: Ketofol, Ketamina, Propofol, Tos inducida por fentanilo, Anestesia general, Ardabil
RESUMO
O fentanil é agora amplamente utilizado para anestesia e alívio da dor. O fentanil com o efeito antinociceptivo de 80 
vezes da morfina foi introduzido na década de 1960 como um anestésico intravenoso em medicina. A incidência de 
tosse relacionada ao fentanil é relatada como sendo cerca de 80-28% e é um efeito colateral indesejável da anestesia. 
Sua principal aplicação é como um anestésico analgésico e sedativo na sala de cirurgia. O objetivo deste estudo foi 
avaliar o efeito do cetofol sobre o fentanil induzido em pacientes submetidos à anestesia geral. Trata-se de um ensaio 
clínico randomizado e duplo-cego que foi realizado em 124 pacientes candidatos a anestesia geral na faixa etária 
de 16 a 60 anos que hospitalizaram em Fatemi e Imam na cidade de Ardabil no ano de 2018. A lista de verificação 
incluiu dados demográficos e clínicos coletados para todos os pacientes. O primeiro grupo recebeu cetamina 2 cc, 
o segundo grupo recebeu propofol 2 cc (10 mg), o terceiro grupo recebeu cetofol 2 cc (propofol 10 mg + cetamina 
10 mg 1: 1) e o quarto grupo recebeu solução salina normal 2 cc por oralmente. Em seguida, fentanil (2 mg / 
kg) foi administrado a cada um dos 4 grupos. Tosse, gravidade e tempo de início foram registrados em intervalos 
de tempo por segundo em cada um dos quatro grupos. Por fim, todos os dados entraram no programa de análise 
estatística e analisados  por métodos estatísticos no SPSS versão 20. Neste estudo, a taxa de sofá foi de 22,6%, 
32,3%, 6,5% e 61,3% em cetamina, propofol, cetofol e grupo controle, respectivamente. O maior atraso na tosse 
foi observado nos receptores de cetofol e propofol, e a maior tosse prematura foi observada no grupo controle. 
Além disso, nenhum dos medicamentos prescritos alterou significativamente a pressão arterial, freqüência cardíaca 
e MAP no grupo controle. Observou-se que o cetofol, cetamina e propofol reduziram significativamente a taxa de 
tosse em comparação com o grupo controle. Os resultados deste estudo mostraram que o cetofol teve o supressor 
da tosse mais induzido pelo fentanil comparado ao placebo e ao propofol, e pode ser usado um bom medicamento 
para os pacientes.
Palavras-chave: Cetofol, Cetamina, Propofol, Tosse induzida por fentanil, Anestesia geral, Ardabil
Introduction
Fentanyl  is  one  of  the  most  common  intravenous  opioids  that  is  used  in  the  operating  room  for 
premedication  in  patients  undergoing  general  anesthetic  or  as  a sedaytiv  drug (1).  Fentanyl has high efficacy 
rate in comparison to other opioids, which leads to relaxation, reduction of anxiety and analgesia and the least 
cardiovascular depression in patients and the release of histamine is minimal (2). Complications  of  fentanyl  are 
reflux  cough  that  usually  benign,  transient   and  self  limiting   but  in some times is  spasmodic  and  explosive 
that  requires to  immediate  treatment (3,4). The  incidence  of  fentanyl-related  cough  is  reported  to  be  about 
28%-80%  and  is one of the undesirable  side  effect  especially  in  patients  with  diseases  such  as increased  brain 
pressure  (ICP), cerebral  aneurysms, trauma  and  brain hernia , aortic  aneurysm  dissociation, open  eye  injury, 
respiratory system diseases, and pneumothorax (5-7). To  reduce  the  incidence  of fentanyl  related cough we 
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used a receptor  agonist for β2,  ephedrine,  lidocaine , ketamine , clonidine , dexamethasone , dexmedetomidine, 
N-methyl  D-aspartate  antagonist,  benzodiazepines , propofol   and  huffing  manoeuvre (8-6). Ketamine  and 
propofol  have  been  used  as  a combination anesthetic  for  surgery  sine  1990  and  in compare to fentanyl  and 
alfentanil  are  safer. The   effect  of  Ketofol , including  analgesia , sodasiuom  with  sustained  hemodynamics 
and  preservation  of  airway  reflexes   is  very  popular  in  short-term  painful  surgery. Combination  of  ketamine 
with  propofol  causes higher procedural  sedation and analgesia (PSA ), reduced  surgical  complications  such 
as  nausea , early  discharge  of  patients  from  the  hospital   and  increased  patient  satisfaction  and  treatment 
staff. The  aim  of  this  study  was  to  determine  the  effect  of  ketofol  on  decreasing fentanyl-related cough in 
patients  candidate for general  anesthesia. 
Materials and methods:
This  clinical  trial  study  was  performed  on  124  patients  with  aged  18-60  years  who admitted  in  Fatemi 
and  Imam  Khomeini  hospitals  of  Ardabil  in  2018 and candidate for general anesthesia. All patients signed the 
consent form and patients  with  asthma,  COPD,  heart  failure, chemical  waste, history  of  chest  surgery, renal 
and  hepatic  dysfunction,  upper  respiratory  infection  in  the  last  4 weeks, smoking, steroid  use, antihistamines 
and  histamine  inhibitors  in  the  last  4  weeks excluded from the study. A checklist  containing  clinical  and 
demographic  information  such  as  type  of  surgery,  blood  pressure  and  median  arterial  pressure, heart  rate, 
incidence  and  duration  of  onset  of  the  cough  were  completed for all patients. Patients  were  divided  into 
four  groups  using simple sampling method and  8  random  blocks  (AABBCCDD). The  first  group  received 
ketamine  0.015  mg / kg, the  second  group  propofol  1.05  mg / kg  and  the  third  group  ketofol  1.05  mg 
/ kg   both  of  which  were  1: 1  and the fourth group received normal  saline. Fentanyl  was administered  as  2 
μg / kg  for  each  of  the  four  groups  and  all  oral  medications  were  discontinued  8  hours  before  surgery. 
Operating   room   temperature  and  other  influencing  factors   such   as   sex  and   age  were  identical  and  then 
the  incidence  of  coughing  severity   and  start  time  were  recorded  at  different  time  intervals. The  severity  of 
coughing  was  recorded  at  intervals  of  0-5-10  seconds  in  each  group  and  coughing  was  less  than  5  seconds 
defined as  early cough  and  after  10  seconds  before  induction  as  a late  cough . Then  patients  underwent 
general  anesthesia with  propofol  and  loosener . Data  were  analyzed  using  descriptive  and  analytical statistical 
methods  in  SPSS version 20. P value  less  than  5%  was  considered  significant . 
Results:
In  this  study, the  average   age  of  patients  in  the  ketamine  group  was  30.35 ± 10.17,  propofol  group  was 
34.54 ± 13.07  the  ketoffol  group  was  35.12 ± 88.9  and  the  control  group  was  36.64 ± 15.26(P=0.220). 
There  was  no  significant  difference  between  sexes  and  age  groups  among  the  studied  groups (Table 1). The 
lowest  and  highest  levels  of  cough  were  in  the  ketoffol  and  control  groups(P=0.001). The  type  of  cough 
among  the  groups  was  statistically  significant (P=0.004). The  highest  levels  of  severe  cough  were seen in  the 
control  group  (22.6%)  and  the  lowest  mild  cough  were seen in ketamine  and ketofol  groups  (6.5%). The 
highest  percentage  of early cough  (less  than  5 seconds)  and  late  cough (after  10 seconds) were seen in  the 
control  group  (22.7%)  which was  statistically  significant. There  were  no  significant  differences  in  heart  rate, 
systolic  and  diastolic  blood  pressure   and  arterial  pressure  in  patients  before  and  after  fentanyl  injection, 
but  the  difference  between  systolic  blood  pressure  and  arterial  pressure  at  the  beginning  and  the  end  of 
the  study  was  statistically  significant. The  highest  reduction  of cough was  observed  in  the  ketoffol  group 
and  the  highest  increase  was  seen in  the  propofol  group (Table 2). The  results  showed  that  in  the  study 
groups, ketofol  significantly  decreased  cough  rates  compared  to  propofol  (p=0.001) and  control  groups 
(P=0.037) but there  was  no  significant  difference  between  ketamine  and  ketophorol. In  comparison   propofol 
and  ketamine  results showed  that  the  severity  of  cough  in  these  two  groups  in compared  to  the  control 
group was statistically  significant. In  terms  of  severity  of  cough   ketofol  significantly  reduced  the  severity  of 
severe  cough  in  compared  to  the  control  group  and  propofol (P=0.005). 
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Table 1: Demographic and clinical characteristics of patients based on study group
Variables 
n
Ketamine Propofol Ketoffol Control 
p-value 
% n % n % n %
Age <20 8 25.8 2 6.5 2 6.5 3 9.7 0.312
30-21 8 25.8 13 41.9 9 29 12 38.7
40-31 7 22.6 7 22.6 9 29 3 9.7
>40 8 25.8 9 29 11 35.5 13 41.93
Sex Male 17 13.7 12 9.7 10 8.1 13 10.5 0.3
Female 14 11.3 19 15.3 21 16.9 18 14.5
ASA Calss1 28 22.6 28 22.6 22 17.7 26 21 0.01
Class2 3 2.4 3 2.4 9 7.2 5 4.1
Type of 
cough
No cough 24 77.4 21 67.7 29 93.5 12 38.5 0.004
Mild cough 2 6.5 3 9.7 2 6.5 7 22.6
Moderate 
cough
2 6.5 3 9.7 0 0 5 16.1
Severe cough 3 9.7 4 12.9 0 0 7 22.6
Duration 
of cough
<5s 1 3.2 4 12.9 0 0 7 22.6 0.002
10-6s 4 12.9 2 6.5 1 3.2 5 16.1
>10s 2 6.5 4 12.9 1 3.2 7 22.6
Table 2: Clinical characteristics of patients in terms of heart rate and blood pressure before and after fentanyl 
injection by study groups
Clinical 
characteristics Group Time Mean
SD p-value 
Pulse rate 
Ketamine
Before 91.22 19.08 0.728
After 92.83 17.21
Propoffol 
Before 89.93 19.81 0.630
After 87.58 18.41
Ketoffol 
Before 92.74 18.46 0.519
After 95.77 18.32
Normal saline 
Before 93.77 22.98 0.773
After 92.19 19.93
Systolic blood 
pressure Ketamine
Before 125.87 11.81 0.673
After 127.32 14.93
Propoffol 
Before 129.87 15.09 0.415
After 126.58 16.47
Ketoffol 
Before 130.77 12.30 0.443
After 133.48 15.19
Normal saline 
Before 132.29 16.38 0.618
After 130.03 19.03
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Diastolic 
blood pressure Ketamine
Before 78.51 11.28 0.510
After 80.29 9.74
Propoffol 
Before 79.16 7.36 0.222
After 76.22 11
Ketoffol 
Before 80.7 12.48 0.502
After 82.83 12.33
Normal saline 
Before 80.09 10.55 0.972
After 80 10.74
Discussion:
In  this  study  the  incidence  of  cough  after  fentanyl  injection  was  22.6%  in  the  ketamine  group  and 
61.3%  in  the  control  group . In  the  study  of  Yeh  et  al,  the  incidence  of  cough  after  fentanyl  injection 
was  2.7%  in  the  recipients  of  ketamine  and  21.6%  in  the  placebo  group  which  was  lower  than  that  in 
the  present  study (9). In  the  study  of  Saleh  et  al,   the  incidence  of  cough  after  receiving  fentanyl  was 
20%  in  the  ketamine  and  53%  in  the  placebo  group  which  was  lower  than  the  current  study (2). In  the 
present  study,  the  most  severe  incidence  of  cough  was seen in  the  control  group  (22.6%)  and  the  lowest 
mild  cough  in  ketofol  and  ketamine groups (6.5%)  but  in  the  study  of  Yeh  and  Saleh  and  colleagues 
the  severity  of  mild  cough  in  the  ketamine  group  was  69%  and  50%  which  higher  than  the current 
study (2,9). In  a study  by  Tang  et  al,  comparing  the  incidence  of  cough  in  different  doses  of  propofol 
after  fentanyl  injection  it  was  observed  that  the  incidence  of  cough  was  40%  in  the  dose  of  1 mg / kg 
propofol,   at  a dose  of  1.5 mg / kg was 6.7% , at  a dose  of 2 mg/ kg was 3.3%  and  at  1.5  and  2 mg / kg, 
all  of patients  had  only  mild  cough (10). In the present study, the incidence of cough after injection of 2 mg / 
kg propofol was 32.3% and 12.9% of patients had severe cough and 9.7% had mild to moderate cough. In  the 
study  of  Sadeghi-nejad   et  al,  the  incidence  of  cough  in  the  receiving  group  of  propofol  with  fentanyl 
was  25.6%  and, in  the  placebo,   group was  74.4%  and  the  severity  of  cough  in  the  propofol  group  was 
90%  mild  and  10%  moderate. In  the  present  study, the  incidence  of  cough  after  injection  of  propofol  was 
9.7%  for  mild  and  moderate  cough  and  12.9%  for  severe  cough which  was  lower  than  that  of  Sadeghi 
Nejad  and  colleagues study (11). 
By comparison  of  propofol  and  placebo  in  reducing  the  incidence  of  cough  in  the  study  by  Firouzan 
et  al, it was observed that  the  incidence  of  cough  in  the  propofol  group  was  9.2%  and, in  the  placebo, 
group  was 40.4%  that  this  amount  was  32.3%  in  the  propofol  group  and  61.3%  in  the  control  group 
(12). The  results  of  this  study  showed  that  the  incidence  of  cough  in  the  ketamine  and  propofol  groups 
was  lower  than  other  studies  but  the  severity  of  coughs  was  lower   which  could  be  due  to  the  injected 
fentanyl  dose,  the  quality  of  injected  drugs  and  the  genotype  of  liver  enzymes  in  patients  in  different 
populations . Also, the  results  of  other  studies  similar  to  those  of  the  present  study  showed  that  ketofol 
is  a very  good  drug  for  reducing  cough  in  patients  receiving  fentanyl  and  can  significantly  reduce  the 
incidence  of  cough . In  the  recent  study,  the  highest  incidence  of  delayed  onset  of  coughing  was  observed 
in  propofol  and  control  groups  and  the  highest  premature  cough  was  observed  in  the  control  group . In 
Saleh  et  al,  the  average   cough  time  in  the  control  group  was  15.7  seconds   in  the  ketamine  group  18.6 
and  in  the  ketamine-dexmedetomidine  group  was 25.8  seconds  and  as  a result,  the  incidence  of  cough  in 
the  Ketodex  group  was  significantly  delayed  which  not in line with  the  present  study (2). In  the  present 
study,  none  of  the  prescribed  drugs  did  not  significantly  change  the  blood  pressure,  heart  rate  and  MAP 
in  the  control  group. In  the  study  of  Yeh  et  al   before  and  after  fentanyl  injection  systolic  and  diastolic 
blood  pressure   as  well  as  heart  rate   had  no  significant  difference in compare to the control  group (9). In 
the  study  of  Firozan  et  al, observed that   systolic  blood  pressure , diastolic  blood  pressure,  average   arterial 
pressure  and  heart  rate  in  propofol  and  placebo  recipients  before  and  after  fentanyl  were  not  significantly 
different  and  administration  of  propofol  did  not  result  in  significant  changes  in  hemodynamics  in  patients 
after  fentanyl  injection (12). 
Studies  have  shown  that  administration  of  propofol, ketamine  and  ketofol  does  not  have  a significant 
effect  on  hemodynamics  in  patients  and this  study  was  in  line  with  other  studies. In  this  study, it  was 
observed  that  ketofol  reduced  the  level  of  cough  compared  to  propofol  and  control   but  no  significant 
correlation  was  found  between  ketamine  and  ketofol. In  comparison   propofol  and  ketamine  also  showed 
that  the  severity  of  cough  in  these  two  groups  was  statistically  significant  compared  to  the  control  group. 
A study  by  Saleh  et  al,  found  that  Ketodox  was  able  to  reduce  the  incidence  of  coughing  over  doses  of 
dexmedotomidine  and  ketamine  in  patients. In  the  study  of  Sadeghi-Nejad  et  al,  the  efficacy  of  propofol 
was  demonstrated  and  found  that  the  drug  could  significantly  reduce  the  incidence  of  cough (11,2). In 
a study  by  Yousef  et  al, it  was  reported  that  ketofol  could  significantly  decrease  the  incidence  of  cough 
Effect of ketofol in reducing cough caused by fentanyl in patients undergoing general anesthesia
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compared  to  propofol which was  similar  to  the  present  study(13). Another  study  by  Sun  et  al,  found  that 
the  administration  of  dezocin  reduced  the  level  of  cough  after  fentanyl  in  the  control  group  from  70% 
to 0 % in  the  case  group (14). In  the  study  of  Guler  et  al,  Ketamine  was  able  to  reduce  the  cough  rate 
after  fentanyl  injection  significantly  compared  to  the  control  group  and  lidocaine (15). Finding  a low-grade 
drug  and  having  the  least  effect  on  hemodynamics of  patients  who  can  reduce  fentanyl  induced  cough  has 
a significant  impact  on  the  satisfaction  of  patients  and  anesthesiologists with  the  anesthetic and  treatment 
process . The  study  also  found  that  ketofol had  the  most suppression in fentanyl  induced  cough and  regarding 
the  non-significant  effect  on  hemodynamics  of  patients  it  can  be  a good  drug  for  patients .
Conclusion:
Finding  a solution  to  reduce  the  complications  of  anesthetic  drugs  is  one  of  the  main goals  of  the  study 
that  is  being  done  in  this  area . The  results  of  this  study  showed  that  ketofol  had  the  highest  fentanyl 
induced  cough  suppression  compared  to  placebo  and  propofol  but  did  not  have  a significant  superiority 
to  ketamine  and  due  to  the  less effect  on  hemodynamics  of  patients  it  can  be  a good  drug  for  patients. 
Ketamine  and  propofol  also  delayed  the  onset  of  coughing   which  was  in  line  with  other  studies. 
Yousefian M., Mohamadian-erdi  A., Birounbar-Fathi Z.
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